Howard Hughes Medical Institute’s Mastercard MA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-177
| Closed | -$101K | – | 304 |
|
|
2025
Q4 | $101K | Hold |
177
| – | – | 0.06% | 18 |
|
|
2025
Q3 | $101K | Buy |
177
+1
| +0.6% | +$574 | 0.06% | 17 |
|
|
2025
Q2 | $98.9K | Buy |
+176
| New | +$97.3K | 0.04% | 17 |
|
|
2023
Q1 | – | Sell |
-30,000
| Closed | -$10.4M | – | 14 |
|
|
2022
Q4 | $10.4M | Hold |
30,000
| – | – | 5.81% | 6 |
|
|
2022
Q3 | $8.53M | Hold |
30,000
| – | – | 2.43% | 18 |
|
|
2022
Q2 | $9.46M | Hold |
30,000
| – | – | 5.11% | 6 |
|
|
2022
Q1 | $10.7M | Hold |
30,000
| – | – | 4.7% | 9 |
|
|
2021
Q4 | $10.8M | Hold |
30,000
| – | – | 4.23% | 10 |
|
|
2021
Q3 | $10.4M | Hold |
30,000
| – | – | 3.52% | 11 |
|
|
2021
Q2 | $11M | Hold |
30,000
| – | – | 3.66% | 8 |
|
|
2021
Q1 | $10.7M | Hold |
30,000
| – | – | 3.64% | 10 |
|
|
2020
Q4 | $10.7M | Buy |
30,000
+5,000
| +20% | +$1.66M | 2.51% | 10 |
|
|
2020
Q3 | $8.45M | Hold |
25,000
| – | – | 2.78% | 13 |
|
|
2020
Q2 | $7.39M | Hold |
25,000
| – | – | 3.02% | 13 |
|
|
2020
Q1 | $6.04M | Buy |
25,000
+5,000
| +25% | +$1.49M | 1.27% | 16 |
|
|
2019
Q4 | $5.97M | Hold |
20,000
| – | – | 2.14% | 15 |
|
|
2019
Q3 | $5.43M | Hold |
20,000
| – | – | 1.52% | 18 |
|
|
2019
Q2 | $5.29M | Hold |
20,000
| – | – | 2.53% | 14 |
|
|
2019
Q1 | $4.71M | Sell |
20,000
-20,000
| -50% | -$4.3M | 1.1% | 18 |
|
|
2018
Q4 | $7.55M | Hold |
40,000
| – | – | 2.39% | 6 |
|
|
2018
Q3 | $8.9M | Sell |
40,000
-20,000
| -33% | -$4.17M | 2.6% | 5 |
|
|
2018
Q2 | $11.8M | Hold |
60,000
| – | – | 2.98% | 6 |
|
|
2018
Q1 | $10.5M | Hold |
60,000
| – | – | 2.73% | 6 |
|
|
2017
Q4 | $9.08M | Hold |
60,000
| – | – | 2.36% | 8 |
|
|
2017
Q3 | $8.47M | Sell |
60,000
-964
| -2% | -$128K | 2.1% | 6 |
|
|
2017
Q2 | $7.4M | Sell |
60,964
-6,073
| -9% | -$720K | 1.35% | 13 |
|
|
2017
Q1 | $7.54M | Sell |
67,037
-5,903
| -8% | -$647K | 1.39% | 12 |
|
|
2016
Q4 | $7.53M | Buy |
72,940
+3,675
| +5% | +$380K | 1.72% | 8 |
|
|
2016
Q3 | $7.05M | Buy |
69,265
+6,289
| +10% | +$603K | 1.82% | 15 |
|
|
2016
Q2 | $5.55M | Sell |
62,976
-7,251
| -10% | -$692K | 1.86% | 16 |
|
|
2016
Q1 | $6.64M | Sell |
70,227
-7,005
| -9% | -$619K | 1.46% | 13 |
|
|
2015
Q4 | $7.52M | Sell |
77,232
-9,155
| -11% | -$896K | 1.14% | 11 |
|
|
2015
Q3 | $7.79M | Sell |
86,387
-916
| -1% | -$86.1K | 1.46% | 8 |
|
|
2015
Q2 | $8.16M | Sell |
87,303
-9,855
| -10% | -$904K | 1.73% | 7 |
|
|
2015
Q1 | $8.39M | Sell |
97,158
-6,060
| -6% | -$526K | 1.14% | 8 |
|
|
2014
Q4 | $8.89M | Buy |
103,218
+5,754
| +6% | +$470K | 2.38% | 7 |
|
|
2014
Q3 | $7.21M | Buy |
97,464
+4,615
| +5% | +$351K | 1.6% | 10 |
|
|
2014
Q2 | $6.82M | Buy |
92,849
+19,097
| +26% | +$1.42M | 1.15% | 11 |
|
|
2014
Q1 | $5.51M | Sell |
73,752
-28,818
| -28% | -$2.25M | 0.78% | 24 |
|
|
2013
Q4 | $8.57M | Buy |
102,570
+2,570
| +3% | +$191K | 1.29% | 9 |
|
|
2013
Q3 | $6.73M | Sell |
100,000
-25,000
| -20% | -$1.57M | 1.03% | 13 |
|
|
2013
Q2 | $7.18M | Buy |
+125,000
| New | +$6.94M | 2.36% | 10 |
|
Other funds holding MA
VCM
VPM
Howard Hughes Medical Institute's MA Position: Q1 2026 in Review
Howard Hughes Medical Institute sold out of Mastercard (MA) in Q1 2026, closing a stake of 177 shares — an estimated $101K sold.
Howard Hughes Medical Institute first reported a position in MA in Q2 2013 and held it in 42 quarters. The position peaked at $11.8M in Q2 2018. 3,603 funds tracked by Wall St. Rank hold MA as of Q1 2026.
- Howard Hughes Medical Institute reported no remaining Mastercard position as of Q1 2026 after selling out during the quarter.
- Howard Hughes Medical Institute sold 177 Mastercard shares in Q1 2026, an estimated $101K.
- Howard Hughes Medical Institute first reported a position in Mastercard in Q2 2013 and held it in 42 quarters.
- Howard Hughes Medical Institute's Mastercard position peaked at $11.8M in Q2 2018.
- 3,603 funds tracked by Wall St. Rank held Mastercard as of Q1 2026.
Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.